NOACS 2016

Learning Objectives

• To describe the recent developments in the management and treatment of atrial fibrillation.
• To identify the risks and benefits of different approaches to stroke prevention in atrial fibrillation.
• To illustrate an evidence based approach to the management of anticoagulation in patients with atrial fibrillation.

Agenda

Click to See Video in Chapters

Faculty

Paul Dorian
MD, MSc, FRCP(C)
Co-Chair
Professor of Medicine Director, Division of Cardiology Dexter Hung-Cho Man Chair in Cardiology University of Toronto
Cardiac Electrophysiologist, St. Michael’s Hospital Toronto

Subodh Verma
MD, PhD, FRCSC, FAHA
Co-Chair
Cardiac Surgeon, St. Michael’s Hospital Professor of Surgery & Pharmacology and Toxicology, University of Toronto
Canada Research Chair in Atherosclerosis Toronto

John Eikelboom
MBBS, MSc, FRCPC
Associate Professor, Division of Hematology & Thromboembolism, Department of Medicine, McMaster University Hami

Neil P. Fam
MD, MSc, FRCPC
Staff Cardiologist Director, Coronary Care Unit, St. Michael’s Hospital
Assistant Professor of Medicine, University of Toronto

Andrew C.T. Ha
MD, MSc, FRCPC
Cardiac Electrophysiology, University Health Network Department of Medicine, University of Toronto

Mario Talajic
MD, FRCPC
Professor and Cardiac Electrophysiologist Chair, Department of Medicine, University of Montréal
Director, Cardiac Genetics Center of the Montreal Heart Institute Montreal

Atul Verma
MD, FRCPC, FHRS
Director, Heart Rhythm Program Southlake Regional Health Centre
Assistant Professor of Medicine, University of Toronto
Co-Chair, CCS AF Guidelines Committee Toronto